Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12543746.
- Also identified by PMC identifier 1771483.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To analyse the visual and angiographic results of photodynamic therapy (PDT) with verteporfin in highly myopic patients with subfoveal choroidal neovascularisation (CNV). PDT was performed on highly myopic patients with subfoveal CNV. The patient population was divided into two groups according to age at onset of CNV (group 1 aged < or = 55 and group 2 aged >55 years old). Best corrected visual acuity (BCVA) and angiographic findings were considered. At the end of follow up group 2 had worse BCVA than group 1. 76% of patients in both groups showed a complete closure of CNV at the end of follow up. Visual prognosis of myopic CNV treated by PDT is influenced by age at onset.
Medical subject headings
- Choroidal Neovascularization
- Myopia
- Photochemotherapy
- Photosensitizing Agents
- Porphyrins